The emergence of new SARS-CoV-2 variants that can spread rapidly and undermine vaccine-induced immunity threatens the end of the COVID-19 pandemic. The delta variant (B.1.617.2) emerged in India and subsequently spread globally ...
Oct 18, 2021
0
59
The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use disorder developed by researchers at the University of Minnesota Medical School.
Sep 7, 2021
0
15
Authorities in the United Kingdom overnight recommended people under 30 be offered an alternative COVID vaccine to the AstraZeneca/Oxford shot.
Apr 8, 2021
0
7
The Therapeutic Goods Administration (TGA) yesterday announced it has provisionally approved AstraZeneca's COVID vaccine for use in Australia.
Feb 17, 2021
0
5
The Therapeutic Goods Administration (TGA) has today provisionally approved Australia's first COVID vaccine, the Pfizer vaccine, paving the way for its rollout to begin in mid-to-late February among high-risk groups.
Jan 25, 2021
0
5
A new study from researchers at the University of British Columbia reveals many parents are willing to accept less rigorous testing and expedited approval of a COVID-19 vaccine.
Oct 7, 2020
0
5
Bonnie Robeson, a senior lecturer at the Johns Hopkins Carey Business School, knows what it's like to take part in an urgent race to find a vaccine or treatment for a lethal malady, such as the current effort to contain the ...
May 29, 2020
0
2
Researchers at Helmholtz Zentrum München, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B. The scientists found ...
Feb 3, 2020
0
2
A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-destruct once they've done their job, making it safe for ...
Jun 24, 2019
0
0
A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial.
Apr 4, 2019
0
55
